IGC Pharma IGC
NYSE IGC
$0.25 +0.00 (+0.20%)
As of: Oct 21, 2026 · 3:54 PM EDT

IGC Pharma (IGC) Non-Current Deferred Tax Liability (2011 - 2012)

Updated

IGC Pharma (IGC) reported Non-Current Deferred Tax Liability of $713,897 for Q3 2013, unchanged from $713,897 a year earlier and unchanged from the prior quarter.

Analysis

IGC Pharma (IGC) Non-Current Deferred Tax Liability (2011 - 2012) Analysis & Trends

Dating back to Q3 2012, IGC Pharma's Non-Current Deferred Tax Liability record includes 5 quarters.

  • Per Business Quant data, the three quarters before Q3 2013 came in at $713,897 (Q2 2013), $713,897 (Q1 2013) and $713,897 (Q4 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 IGC Pharma 24.10 Mn 21.34 Mn 55,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 713,897.00
Sep 30, 2012 713,897.00
Jun 30, 2012 713,897.00
Mar 31, 2012 713,897.00
Dec 31, 2011 713,897.00
API Access

IGC Pharma Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=IGC&period=max&api_key=YOUR_API_KEY